Sequenom is a San Diego biotechnology company specializing in non-invasive prenatal testing and genetic diagnostics.
Founded in 1994 in San Diego, US, Sequenom develops genetic testing for maternal-fetal health, including non-invasive prenatal testing, hereditary cancer screening and genetic counseling. The company raised USD 302.00 mn in a Trade Sale round led by Laboratory Corporation of America Holdings on February 1, 2000, which was also its IPO, and has completed 8 deals to date. In fiscal 2015 it reported revenue of USD 128.28 mn and an EBITDA of USD 2.26 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in